Agatha Kwasnik
About Agatha Kwasnik
Agatha Kwasnik is the Principal Rhythmia Mapping Specialist at Boston Scientific with extensive experience in electrophysiology and biomedical engineering.
Current Position at Boston Scientific
Agatha Kwasnik is currently employed as a Principal Rhythmia Mapping Specialist at Boston Scientific. She began this role in 2020 and operates out of Chicago, Illinois, United States. In her current capacity, she focuses on advancing the capabilities and applications of Rhythmia mapping technology.
Previous Roles at Boston Scientific
Prior to her current position, Agatha Kwasnik worked as a Senior Rhythmia Mapping Specialist at Boston Scientific from 2018 to 2020. During this period, she contributed to the development and implementation of electrophysiology solutions, aiming to improve patient outcomes through technological innovation.
Experience with Abbott and St. Jude Medical
Agatha Kwasnik served as a Principal Electrophysiology Technical Service Specialist at Abbott from 2017 to 2018. Before that, she held various roles at St. Jude Medical, including Senior Electrophysiology Technical Service Specialist from 2014 to 2017 and Electrophysiology Technical Service Specialist from 2010 to 2014. Her work focused on delivering technical support and advancing electrophysiology technologies.
Early Career and Research Roles
Early in her career, Agatha Kwasnik held the position of Associate Research Scientist at Talecris Biotherapeutics, Inc. in 2009. She also worked as a Research Assistant at the Georgia Institute of Technology's Advanced Materials Lab from 2008 to 2010, and at Northwestern University's Cell and Molecular Biology Lab in 2007. These roles involved conducting critical research in biomedical engineering and materials science.
Education in Biomedical Engineering
Agatha Kwasnik earned her degree in Biomedical Engineering from Georgia Institute of Technology, completing her studies in 2010. Her academic foundation in this field has been instrumental in her career, providing deep insights into the medical device industry.